In contrast, CEA and other tumor markers cannot be used to distinguish pulmonary carcinoids from other thoracic malignancies [8]. Moreover, distinguishing between benign nodules and carcinoids using chest CT and other imaging modalities remains challenging [9]. This evidence concerns the gene CEACAM5 and carcinoid tumor.